Literature DB >> 34491898

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Abnormal Serum Potassium Level.

Y Joseph Hwang1,2, Beini Lyu3, Alex R Chang4, Lesley A Inker5, Morgan E Grams6,2,7,8, Jung-Im Shin2,7,8.   

Abstract

Entities:  

Keywords:  SGLT2i; hyperkalemia; hypokalemia; potassium; sodium-glucose cotransporter-2 inhibitor; type 2 diabetes mellitus

Mesh：

Substances：

Year:  2021        PMID： 34491898      PMCID： PMC8425629          DOI： 10.2215/CJN.02130221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  3 in total

1.  Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure.

Authors:  Javed Butler; Faiez Zannad; David Fitchett; Bernard Zinman; Audrey Koitka-Weber; Maximilian von Eynatten; Isabella Zwiener; Jyothis George; Martina Brueckmann; Alfred K Cheung; Christoph Wanner
Journal:  Circ Heart Fail       Date:  2019-06-05       Impact factor: 8.790

2.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Authors:  Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Gordon Law; Mehul Desai; David R Matthews
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

3.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Authors:  Vlado Perkovic; Meg J Jardine; Bruce Neal; Severine Bompoint; Hiddo J L Heerspink; David M Charytan; Robert Edwards; Rajiv Agarwal; George Bakris; Scott Bull; Christopher P Cannon; George Capuano; Pei-Ling Chu; Dick de Zeeuw; Tom Greene; Adeera Levin; Carol Pollock; David C Wheeler; Yshai Yavin; Hong Zhang; Bernard Zinman; Gary Meininger; Barry M Brenner; Kenneth W Mahaffey
Journal:  N Engl J Med       Date:  2019-04-14       Impact factor: 91.245
  3 in total
  1 in total

1.  Glucose-Lowering Agents and the Risk of Hypoglycemia: a Real-world Study.

Authors:  Beini Lyu; Y Joseph Hwang; Elizabeth Selvin; Brian C Jameson; Alex R Chang; Morgan E Grams; Jung-Im Shin
Journal:  J Gen Intern Med       Date:  2022-07-13       Impact factor: 6.473
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.